Abstract:Aims/hypothesisAlthough thiazolidinediones are now widely used to treat type 2 diabetes, their mechanism of action remains largely unknown. They are agonists for the transcription factor PPARγ, and in addition to their insulin-sensitising effects, they can promote adipogenesis and control gene expression in adipose tissues. We have explored the effect of rosiglitazone on insulin-mediated induction of pivotal genes involved in lipid metabolism and thermogenesis in brown fat. The genes studied were: (1) lipoprotein lipase (lpl), which is involved in lipid uptake; (2) hormone-sensitive lipase (hsl), which mobilises fatty acids from stored triglycerides; (3) fatty acid synthase (fas), which regulates de novo lipogenesis; and (4) the uncoupling proteins (ucp) 1 and 3, which control thermogenesis.MethodsWe used fetal rat primary brown adipocytes cultured with insulin, rosiglitazone or both combined. Then, we studied gene expression by northern and western blotting, as well as ‘run-on’ and gel-shift assays to identify binding of potential transcription factors to the fas promoter.ResultsExposure to rosiglitazone for 24 h induced ucp-1, lpl and hsl gene expression and when rosiglitazone was combined with insulin a synergistic effect on lpl and ucp-3 mRNA expression was produced. These effects were consistent with increased LPL and HSL activities as well as respiration rates, mainly in response to exogenous palmitate. In contrast, treatment with rosiglitazone did not alter FAS mRNA basal levels but prevented the induction elicited by insulin in a time- and dose-dependent manner. Correspondingly diminished FAS protein levels and activity, as well as cellular lipid content, were observed, indicating an antilipogenic action of rosiglitazone in brown adipocytes. Furthermore, rosiglitazone impaired insulin increase in the FAS transcription rate by antagonising insulin-induced binding of upstream stimulatory factors to the E-box consensus sequence in the FAS promoter and insulin-induced binding of activating protein-1.Conclusions/interpretationRosiglitazone prevents insulin-induced up-regulation of the main lipogenic enzyme but increases the expression of those enzymes involved in lipid uptake and mobilisation, favouring fatty acid utilisation through uncoupled respiration.

Rosiglitazone-induced changes in the oxidative stress metabolism and fatty acid composition in relation with trace element status in the primary adipocytes

Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats

Rosiglitazone Via Upregulation of Akt/Enos Pathways Attenuates Dysfunction of Endothelial Progenitor Cells, Induced by Advanced Glycation End Products

The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome

Rosiglitazone up-regulates lipoprotein lipase, hormone-sensitive lipase and uncoupling protein-1, and down-regulates insulin-induced fatty acid synthase gene expression in brown adipocytes of Wistar rats

The effects of Rosiglitazone on the levels of cytokine in patients with IGT and metabolic syndrome

Rosiglitazone remodels the lipid droplet and britens human visceral and subcutaneous adipocytes ex vivo

Role and Mechanism of Rosiglitazone on the Impairment of Insulin Secretion Induced by Free Fatty Acids on Isolated Rat Islets

The autophagic regulation of rosiglitazone-promoted adipocyte browning

Effects of Rosiglitazone on Adiponectin Expression in 3T3-L1 Adipocytes at High Levels of Both Testosterone and Insulin in Vitro Culture

Impact of Sex on the Therapeutic Efficacy of Rosiglitazone in Modulating White Adipose Tissue Function and Insulin Sensitivity

Effects of Rosiglitazone on Lipid Peroxidation in Nonalcoholic Steatohepatitis Rats

Adipose tissue macrophages secrete small extracellular vesicles that mediate rosiglitazone-induced insulin sensitization

Novel Effects of Rosiglitazone on SMAD2 and SMAD3 Signaling in White Adipose Tissue of Diabetic Rats

Effects of Rosiglitazone on Free Fatty Acids in Type 2 Diabetes Mellitus

Effects of Rosiglitazone on Adiponectin Expression in Cultured Adipocytes of Obese Patients

Effects of high fat diet and rosiglitazone treatment on insulin signal system gene expression

Sex Dimorphic Actions of Rosiglitazone in Generalised Peroxisome Proliferator-Activated Receptor-Γ (Ppar-Γ)-deficient Mice

Rosiglitazone Promotes Bone Marrow Adipogenesis to Impair Myelopoiesis under Stress

Bidirectional Modulation of Insulin Action by Reactive Oxygen Species in 3T3‑L1 Adipocytes.

Adipocyte-targeted delivery of rosiglitazone with localized photothermal therapy for the treatment of diet-induced obesity in mice